APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old

Neurology

Volumn 54, Issue 2, 2000, Pages 412-415

  Juva, Kati ^a   Verkkoniemi, A ^b   Viramo, P ^b   Polvikoski, T ^b   Kainulainen, K ^b   Kontula, K ^b   Sulkava, R ^b  

^a NONE   (Finland)

^b NONE

Author keywords

APOE; Dementia; Mortality

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; GENOTYPE; HUMAN; MORTALITY; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; ALLELE; FEMALE; FOLLOW UP; GENETICS; MALE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034711620     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.412     Document Type: Article

References (23)

1. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
3. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ∈4 allele distribution in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342: 710-711.
4. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes in late onset Alzheimer's disease: population-based study. BMJ 1994;309:636-638.
5. van Duijn C, Kniff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
6. Blacker D, Haines JL, Rodes L, et al. APOE4 and age at onset of Alzheimer's disease: the NIMH genetic initiative. Neurology 1997;48:139-147.
7. Reed T, Carmelli D, Swan G, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ∈4 allele. Arch Neurol 1994;51:1189-1192.
8. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the APOE-∈4 allele in nondemented older adults. Neurology 1995;45:2203-2206.
9. Berr C, Dufoil C, Brousseau T, et al. Early effect of APOE-∈4 allele on cognitive results in a group of highly performing subjects: the EVA study. Neurosci Lett 1996;218:9-12.
10. Soininen H, Riekkinen P. Apolipoprotein E, memory, Alzheimer's disease. Trends Neurosci 1996;19:224-228.
11. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
12. Helkala E-L, Koivisto K, Hänninen T, et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett 1996;240:17-180.
13. Kalmijn S, Feskens, EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein ∈4 allele, cognitive decline in a community-based study of elderly men. Stroke 1996;27: 2230-2235.
14. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ∈4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, third ed., revised (DSM-III-R). Washington, DC: APA, 1987.
17. Syvänen A-C, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in genotyping of apolipoprotein E. Genomics 1990;8:684-692.
18. Davignon J, Gregg RE, Sung CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
19. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.
20. Tilvis R, Strandberg T, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-715.
21. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53: 418-422.
22. Sulkava R, Kainulainen K, Verkkoniemi A, et al. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiol Aging 1996;17:373-376.
23. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ∈4 dementia and cognitive decline in a population sample. Lancet 1995;345:1387-1390.